Revolutionizing Facial Aesthetics: FDA Approves JUVÉDERM® VOLUMA® XC for Temple Hollowing

In the ever-evolving landscape of aesthetic medicine, breakthroughs often come in the form of innovative treatments that redefine beauty standards and enhance self-confidence. The recent approval by the U.S. Food and Drug Administration (FDA) of JUVÉDERM® VOLUMA® XC for injection in the temple region marks a significant advancement in facial rejuvenation options. This approval, granted to Allergan Aesthetics, is poised to transform how we address moderate to severe temple hollowing in adults over the age of 21.

Discover a renewed confidence with JUVÉDERM® VOLUMA® XC for injection in the temple region, now offered by Dr. Alexander Rivkin at Westside Aesthetics in Los Angeles. With Dr. Rivkin’s expertise and personalized approach, patients can expect natural-looking results and a tailored treatment plan designed to meet their unique aesthetic

Understanding Temple Hollowing

Temple hollowing, also known as temporal hollowing, is a common concern that occurs as part of the natural aging process. It is characterized by a loss of volume and deepening of the hollow area in the temples, often leading to a sunken or aged appearance. This phenomenon can be attributed to factors such as fat and bone loss, along with changes in skin elasticity over time.

Introducing JUVÉDERM® VOLUMA® XC

JUVÉDERM® VOLUMA® XC is part of the renowned JUVÉDERM® family of dermal fillers, known for their effectiveness in restoring volume and contour to various facial areas. With its FDA approval for temple hollowing, our aesthetics team can now utilize JUVÉDERM® VOLUMA® XC to address this specific concern.

The key component of JUVÉDERM® VOLUMA® XC is hyaluronic acid (HA), a naturally occurring substance in the body that helps maintain hydration and volume in the skin. When injected into the temple region, JUVÉDERM® VOLUMA® XC replenishes lost volume, fills in hollow areas, and creates a more youthful and harmonious facial profile.

Benefits of JUVÉDERM® VOLUMA® XC for Temple Hollowing

• Non-Surgical Solution: Unlike invasive procedures such as surgery or implants, JUVÉDERM® VOLUMA® XC offers a non-surgical option for addressing temple hollowing. This means minimal downtime and a more convenient treatment experience for patients.
• Natural-Looking Results: The advanced formulation of JUVÉDERM® VOLUMA® XC is designed to provide natural-looking results. By restoring volume in a targeted manner, the filler helps achieve a refreshed appearance without looking overdone.
• Customized Treatment: Each patient’s facial anatomy and aesthetic goals are unique. With JUVÉDERM® VOLUMA® XC, Dr. Rivkin can tailor the treatment to suit individual needs, ensuring a personalized and satisfying outcome.

Consultation and Treatment Process

Before receiving JUVÉDERM® VOLUMA® XC injections at Westside Aesthetics, plan to undergo a comprehensive consultation with Dr. Rivkin. During this consultation, he will assess your concerns, discuss your expectations, and develop a customized treatment plan to achieve optimal results.

The injection process is relatively quick and typically well-tolerated under the care of our experienced professionals. Patients may experience mild, temporary side effects such as redness, swelling or bruising at the injection site, which typically resolve within a few days.

Final Thoughts

The FDA approval of JUVÉDERM® VOLUMA® XC for temple hollowing represents a significant advancement in the field of facial aesthetics. By offering a safe, effective and non-surgical solution for addressing this common aging concern, Allergan Aesthetics continues to empower individuals to look and feel their best at every stage of life.

If you’re interested in learning more about JUVÉDERM® VOLUMA® XC and whether it’s right for you, we encourage you to schedule a consultation with Dr. Alexander Rivkin at Westside Aesthetics today. Embrace the opportunity to enhance your natural beauty and regain confidence in your appearance with this innovative treatment option.